Fatty Livers is a condition that is becoming very
Post# of 416
If this study, or any of the other studies that are currently in process are completed this a high degree of success, we are in for one exciting ride. Consider the following:
This traded at .70 18 months ago w/ no trial results. It ran to .14 earlier this year....again w/ no news. I think a dollar or more is a conservative forecast w/ positive trial results. However, you have to keep in mind that once they prove the technology works on one trial, the likelihood that it works for many ailments is extremely probable. That being said a multiple dollars plus is definitely a possibility.
Don't be surprised if after the release of just one successful study we login to our trading account and find ENDV trading for $3.50 a share. It's happened to other stocks and it could happen here.
Endonovo Therapeutics, Inc. (ENDV) Stock Research Links
Never argue with stupid people, they will drag you down to their level and then beat you with experience.
Get .... PrivacyLok https://cyberidguard.com/
Try SafeVchat: https://cyberidguard.com/
My comments are only my opinion and are not to be used for investment advice.
Please conduct your own due diligence before choosing to buy or sell any stock.